PODOS Klinika Leczenia Ran

At PODOS Klinika Leczenia Ran in Warsaw, clinical research in Diabetology focuses on skin and connective tissue diseases linked to difficult-to-heal foot wounds. The studies are centered on diabetic foot ulcers and related diabetic foot infections, with the goal of improving wound closure, safety, and overall treatment effectiveness.

• Testing new topical approaches for non-healing diabetic foot ulcers
• Evaluating treatment options for moderate to severe diabetic foot infections
• Assessing safety, tolerability, and wound-healing outcomes

This area of research is important for patients facing chronic foot complications, where better therapies may help reduce infection risk and support healing.

Another major focus at the site is the study of venous leg ulcers and chronic venous ulcers, both of which fall under skin and connective tissue diseases. These trials are designed to improve wound bed preparation, support debridement, and test whether new treatments can help stubborn ulcers heal more effectively.

• Investigating therapies for therapy-resistant chronic venous ulcers
• Evaluating wound debridement and wound bed preparation strategies
• Comparing new treatments with placebo to measure healing benefit

The research reflects a strong clinical interest in long-term wound management, especially for ulcers that have not responded well to standard care.

The site also contributes to studies in bacterial infections and mycoses, with a practical emphasis on infection control in wound-related disease. These trials aim to assess whether new anti-infective treatments can improve clinical response while remaining safe and well tolerated for adults with serious wound infections.

• Studying novel treatments for infected diabetic foot wounds
• Comparing clinical response against established antibiotic therapy
• Monitoring safety and tolerability in patients with wound-related infections

This research supports better management of infection in complex wounds, an important step in helping patients avoid worsening tissue damage and prolonged healing.

The clinical trial portfolio at PODOS Klinika Leczenia Ran includes research into new therapies for chronic, non-healing wounds, with a focus on improving closure rates and overall wound recovery. Across these studies, investigators are exploring whether emerging treatments can offer meaningful benefits for patients with persistent ulcers that have been difficult to treat.

• Exploring new wound-healing therapies for long-term ulcers
• Measuring complete wound closure as a key outcome
• Assessing whether newer options can outperform placebo or standard care

Together, these trials show a research environment dedicated to practical advances in wound healing, infection management, and better outcomes for people with chronic lower-limb wounds.